Inura had the pleasure to attend the Startup DAYS 2020 and connect with the brilliant minds that are shaping the future of innovation
The Startup DAYS fosters stimulating collaboration between startups, investors, corporates, support organizations, and academia. As they say, “Game changers & Changemakers from all around the world gathering around innovation.” These two days were a unique opportunity for Inura to grow our network, learn from the experts, and meet potential partners, supporters, corporates, and investors.
Due to the COVID-19 pandemic situation, the Startup DAYS had to comply with the social distancing normative rules. Therefore, this year 650 participants on both days were allowed on-site. Inura had the honour to be one of them. Our team cherished the opportunity to enrich our project while learning. We had the chance to connect with investors and supporters in the 1:1 meetings that have given us an excellent future progress perspective. We want to thank all of them for the open, engaging, and helpful discussions held during these two days.
Startup DAYS are also an excellent opportunity to learn. Inura attended some of the interesting and instructive masterclasses and pitches provided during these two days. Moreover, we would like to congratulate all startups that pitched their projects, and to the winners, the high level was astonishing and very inspiring. We will continue working hard to be on the stage for next year!
To conclude, we would like to warmly thank the organizar and helpers, who unionized a fantastic event in such difficult times. Many thanks to the Startup INVEST team for this fruitful Startup DAYS!
Inura Medical AG (“Inura”) is a Swiss start-up company with a clear vision to make a difference in women’s health. Inura’s product is an innovative, first-of-a-kind “urethral ovulum” that utilizes a novel route of drug administration to treat diseases of the bladder and lower urinary tract. Inura’s technology results from decades of work in urology by Professor Grant S. Mulholland, a renowned surgeon, academic, and past President of the American Urology Association. The first indication we are addressing with the ovulum is a chronic disease, named overactive bladder (OAB). More details on https://inuramedical.ch/.